Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges-Reference-Cited by-同舟云学术

Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges

Published:2024-01-19 Issue:2 Volume:134 Page:138-142
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circulation Research

Author:

Mattiazzi Alicia¹^ORCID,Kranias Evangelia G.²^ORCID

Affiliation:

1. Centro de Investigaciones Cardiovasculares, Centro Cientifico Tecnologico-La Plata CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas), Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina (A.M.).

2. Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, OH (E.G.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference25 articles.

1. Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase.

2. Studies on phosphorylation of canine cardiac sarcoplasmic reticulum by calmodulin-dependent protein kinase.

3. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart

4. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

5. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-10

2. Correction to: Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges;Circulation Research;2024-03